Larvol Delta - Asha-Therapeutics-Announces-the-Nomination-of-a-Novel-IntraMolecular-Glue-Development-Candidate-ASHA624-as-a-Disease-Modifying-Therapeutic-for-Amyotrophic-Lateral-Sclerosis

ASHA-624 - Asha Therap

https://www.businesswire.com/news/home/20240401486293/en/Asha-Therapeutics-Announces-the-Nomination-of-a-Novel-Intra-Molecular-Glue-Development-Candidate-ASHA-624-as-a-Disease-Modifying-Therapeutic-for-Amyotrophic-Lateral-Sclerosis

Apr 2, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev